@ARTICLE{
author={Mirjacic-Martinovic Katarina M,Vuletic Ana M,Tisma-Miletic Nevena,Matkovic Suzana V,Gavrilovic Dusica,Ninkovic Aleksandra Z,Jurisic Vladimir B,Babovic Nada Lj},
year={2024},
title={Circulating IL-6 is associated with disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy},
journal={JOURNAL OF CLINICAL PATHOLOGY},
volume={77},
number={5},
pages={343-351},
document_type={Article},
} 

@ARTICLE{
author={Mirjacic-Martinovic Katarina M,Vuletic Ana M,Tisma-Miletic Nevena,Nedeljkovic Milica D,Babovic Nada Lj,Matkovic Suzana V,Jurisic Vladimir B},
year={2023},
title={Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients},
journal={INNATE IMMUNITY},
volume={29},
number={3-4},
pages={37-44},
document_type={Article},
} 

@ARTICLE{
author={Mirjacic-Martinovic Katarina M,Vuletic Ana M,Malisic Emina J,Srdic-Rajic Tatjana V,Tisma-Miletic Nevena,Babovic Nada Lj,Jurisic Vladimir B},
year={2022},
title={Increased circulating TGF-beta 1 is associated with impairment in NK cell effector functions in metastatic melanoma patients},
journal={GROWTH FACTORS},
volume={40},
number={5-6},
pages={231-239},
document_type={Article},
} 

@ARTICLE{
author={Nikic Predrag Z,Babovic Nada Lj,Dzamic Zoran M,Salma Svetlana,Stojanovic Vesna,Matkovic Suzana V,Pejcic Zoran,Juskic Kristina,Soldatovic Ivan A},
year={2022},
title={Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting},
journal={FRONTIERS IN ONCOLOGY},
volume={12},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Vuletic Ana M,Konjevic Gordana M,Larsen Annette K,Babovic Nada Lj,Jurisic Vladimir B,Krivokuca Ana M,Mirjacic-Martinovic Katarina M},
year={2020},
title={Interleukin-4-induced natural killer cell antitumor activity in metastatic melanoma patients},
journal={EUROPEAN CYTOKINE NETWORK},
volume={31},
number={3},
pages={104-112},
document_type={Article},
} 

@ARTICLE{
author={Todorovic Vladimir,...,Babovic Nada Lj,...,Cetnikovic Bojana,Ceric Timur,...,Dzamic Zoran M,Dzodic Radan R,Eri Zivka,...,Knezevic-Usaj Slavica F,Kovcin Vladimir N,...,Markovic Ivan Z,Markovic Milan,Mijalkovic Nenad,...,Pantelic Aleksandra,Popovic Lazar S,Radosavljevic Davorin Z,...,Radulovic Sinisa S,...,Rosic Ivana,...,Stamatovic Ljiljana,...,Tesanovic Dusanka D,Tomasevic Zorica I,Tomasevic Zoran M,...,Vasovic Suzana,Vicko Ferenc,...,Zaric Bojan,...,(broj koautora 65)},
year={2019},
title={AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan)},
journal={JOURNAL OF BUON},
volume={24},
number={5},
pages={2180-2197},
document_type={Article},
} 

@ARTICLE{
author={Kandolf-Sekulovic Lidija O,...,Babovic Nada Lj,...,(broj koautora 38)},
year={2018},
title={Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries},
journal={EUROPEAN JOURNAL OF CANCER},
volume={104},
number={},
pages={201-209},
document_type={Article},
} 

@ARTICLE{
author={Konjevic Gordana M,Vuletic Ana M,Mirjacic-Martinovic Katarina M,Krivokuca Ana M,Jankovic Radmila N,Babovic Nada Lj},
year={2017},
title={Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines},
journal={JOURNAL OF MEMBRANE BIOLOGY},
volume={250},
number={5},
pages={507-516},
document_type={Article},
} 

@ARTICLE{
author={Mirjacic-Martinovic Katarina M,Vuletic Ana M,Babovic Nada Lj,Dzodic Radan R,Konjevic Gordana M,Jurisic Vladimir B},
year={2017},
title={Attenuated in vitro effects of IFN-alpha, IL-2 and IL-12 on functional and receptor characteristics of peripheral blood lymphocytes in metastatic melanoma patients},
journal={CYTOKINE},
volume={96},
number={},
pages={30-40},
document_type={Article},
} 

@ARTICLE{
author={Kandolf-Sekulovic Lidija O,...,Babovic Nada Lj,...,(broj koautora 37)},
year={2017},
title={More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments},
journal={EUROPEAN JOURNAL OF CANCER},
volume={75},
number={},
pages={313-322},
document_type={Article},
} 

@ARTICLE{
author={Mirjacic-Martinovic Katarina M,Babovic Nada Lj,Dzodic Radan R,Jurisic Vladimir B,Ninkovic Aleksandra Z,Konjevic Gordana M},
year={2016},
title={Beneficial in-vitro effects of interleukin-2, interleukin-12, and their combination on functional and receptor characteristics of natural killer cells in metastatic melanoma patients with normal serum lactate dehydrogenase levels},
journal={MELANOMA RESEARCH},
volume={26},
number={6},
pages={551-564},
document_type={Article},
} 

@ARTICLE{
author={Mirjacic-Martinovic Katarina M,Srdic Tatjana V,Babovic Nada Lj,Dzodic Radan R,Jurisic Vladimir B,Konjevic Gordana M},
year={2016},
title={Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma},
journal={JOURNAL OF CLINICAL PATHOLOGY},
volume={69},
number={4},
pages={300-306},
document_type={Article},
} 

@ARTICLE{
author={Mirjacic-Martinovic Katarina M,Babovic Nada Lj,Dzodic Radan R,Jurisic Vladimir B,Matkovic Suzana V,Konjevic Gordana M},
year={2015},
title={Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients},
journal={JOURNAL OF TRANSLATIONAL MEDICINE},
volume={13},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Blay Jean-Yves,...,Babovic Nada Lj,...,(broj koautora 18)},
year={2015},
title={Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial},
journal={LANCET ONCOLOGY},
volume={16},
number={5},
pages={531-540},
document_type={Article},
} 

@ARTICLE{
author={Kandolf-Sekulovic Lidija O,Babovic Nada Lj,Jokic Neven,Balic Mirjana,Nikolin Borislava L,Nikolic Dejan V,Janjic Zlata M,Mijuskovic Zeljko P,Rajovic Milica I,Novakovic Marijan,Vrbic Svetislav,Pejcic Ivica,Kovacevic Predrag T,Mihajlovic Dragan,Roganovic Tatjana,Vicko Ferenc,Nikolic Jelena Ratko,Marinkovic Marija D,Bizetic Zorana},
year={2015},
title={Clinicopathological characteristics, diagnosis and treatment of melanoma in Serbia - the Melanoma Focus Study},
journal={VOJNOSANITETSKI PREGLED},
volume={72},
number={4},
pages={312-316},
document_type={Article},
} 

@ARTICLE{
author={Mirjacic-Martinovic Katarina M,Babovic Nada Lj,Dzodic Radan R,Jurisic Vladimir B,Tanic Nikola T,Konjevic Gordana M},
year={2014},
title={Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients},
journal={MELANOMA RESEARCH},
volume={24},
number={4},
pages={295-304},
document_type={Article},
} 

@ARTICLE{
author={Konjevic Gordana M,Mirjacic-Martinovic Katarina M,Vuletic Ana M,Babovic Nada Lj},
year={2012},
title={In vitro increased natural killer cell activity of metastatic melanoma patients with interferon-alpha alone as opposed to its combination with 13-cis retinoic acid is associated with modulation of NKG2D and CD161 activating receptor expression},
journal={JOURNAL OF BUON},
volume={17},
number={4},
pages={761-769},
document_type={Article},
} 

@ARTICLE{
author={Mirjacic-Martinovic Katarina M,Konjevic Gordana M,Babovic Nada Lj,Inic Momcilo M},
year={2011},
title={The Stage Dependent Changes in NK Cell Activity and the Expression of Activating and Inhibitory NK Cell Receptors in Melanoma Patients},
journal={JOURNAL OF SURGICAL RESEARCH},
volume={171},
number={2},
pages={637-649},
document_type={Article},
} 

@ARTICLE{
author={Konjevic Gordana M,Mirjacic-Martinovic Katarina M,Vuletic Ana M,Babovic Nada Lj},
year={2010},
title={In-vitro IL-2 or IFN-alpha-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients},
journal={MELANOMA RESEARCH},
volume={20},
number={6},
pages={459-467},
document_type={Article},
} 

@ARTICLE{
author={Konjevic Gordana M,Mirjacic-Martinovic Katarina M,Jurisic Vladimir B,Babovic Nada Lj,Spuzic Ivan},
year={2009},
title={Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3-CD16+NK cells},
journal={BIOMARKERS},
volume={14},
number={4},
pages={258-270},
document_type={Article},
} 

@ARTICLE{
author={Bjelogrlic Snezana K,Radulovic Sinisa S,Babovic Nada Lj},
year={2008},
title={Molecular targeting agents in renal cell carcinoma: Present strategies and future perspectives},
journal={CURRENT PHARMACEUTICAL DESIGN},
volume={14},
number={11},
pages={1058-1077},
document_type={Review},
} 

@ARTICLE{
author={Konjevic Gordana M,Mirjacic-Martinovic Katarina M,Vuletic Ana M,Jovic Viktor,Jurisic Vladimir B,Babovic Nada Lj,Spuzic Ivan},
year={2007},
title={Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients},
journal={CLINICAL & EXPERIMENTAL METASTASIS},
volume={24},
number={1},
pages={1-11},
document_type={Article},
} 

@ARTICLE{
author={Juranic Zorica D,Stanojevic-Bakic Nevenka,Zizak Zeljko S,Babovic Nada Lj,Radovic-Kovacevic V,Stanojkovic Tatjana P,Dzodic Radan R},
year={2003},
title={Antimelanoma immunity in vitiligo and melanoma patients},
journal={NEOPLASMA},
volume={50},
number={4},
pages={305-309},
document_type={Article},
} 

@ARTICLE{
author={Jelic Svetislav B,Stamatovic Ljiljana,Vucicevic Slavko S,Petrovic Zeljko M,Kreacic Miroslav,Babovic Nada Lj,Jovanovic Natasa,Mikic Anton A,Gavrilovic Dusica},
year={2002},
title={Use of high-dose cytarabine to enhance cisplatin cytotoxicity - effects on the response and overall survival rates of advanced head and neck cancer patients},
journal={EUROPEAN JOURNAL OF CANCER},
volume={38},
number={11},
pages={1478-1489},
document_type={Article},
} 

@ARTICLE{
author={Jelic Svetislav B,Babovic Nada Lj,Kovcin Vladimir N,Milicevic N,Milanovic Nenad,Popov Ivan P,Radosavljevic Davorin Z},
year={2002},
title={Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study},
journal={MELANOMA RESEARCH},
volume={12},
number={1},
pages={91-98},
document_type={Article},
} 

@ARTICLE{
author={Jelic Svetislav B,Babovic Nada Lj,Stamatovic Ljiljana,Kreacic Miroslav,Matkovic Suzana V,Popov Ivan P},
year={2001},
title={Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study},
journal={MEDICAL ONCOLOGY},
volume={18},
number={3},
pages={189-195},
document_type={Article},
} 

@ARTICLE{
author={Jelic Svetislav B,Mitrovic LB,Radosavljevic Davorin Z,Elezar E,Babovic Nada Lj,Kovcin Vladimir N,Tomasevic Zorica I,Kovacevic S,Gavrilovic Dusica,Radulovic Sinisa S},
year={2001},
title={Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study},
journal={LUNG CANCER},
volume={34},
number={1},
pages={1-13},
document_type={Article},
} 

@ARTICLE{
author={Babovic Nada Lj,Jelic Svetislav B,Jovanovic V},
year={2000},
title={Primary non-Hodgkin lymphoma of the breast. Is it possible to avoid mastectomy?},
journal={JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH},
volume={19},
number={2},
pages={149-154},
document_type={Article},
} 

@ARTICLE{
author={Jelic Svetislav B,Babovic Nada Lj,Kreacic Miroslav,Matkovic Suzana V,Milanovic Nenad,Gavrilovic Dusica,Tomasevic Zoran M},
year={1999},
title={Epirubicin 150 mg/m(2)-cisplatin versus epirubicin 180 mg/m(2)-cisplatin for advanced soft tissue sarcoma},
journal={INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH},
volume={19},
number={4},
pages={129-138},
document_type={Article},
} 

